BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huguenot M, Bruhm AC, Essig M. Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report. World J Clin Cases 2022; 10(14): 4502-4508 [PMID: 35663093 DOI: 10.12998/wjcc.v10.i14.4502]
URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4502.htm
Number Citing Articles
1
Azusa Ishii, Tomofumi Shibata, Yohei Tsunoda, Takafumi Kayukawa, Masahiro Kobayashi, Masami Orinaka, Shoko Miyamatsu, Yoshio Ryuge, Shuichi Asano, Ichidai Tanaka. Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case reportBMC Geriatrics 2024; 24(1) doi: 10.1186/s12877-024-04683-1
2
Patrick D. Meek, Brian Hemstreet. Emerging therapies for eosinophilic esophagitisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2023; 43(4): 338 doi: 10.1002/phar.2783
3
Margarida Gomes, Ana Mendes, Filipa Ferreira, Joana Branco, Fernanda S. Tonin, M. Elisa Pedro, Piotr K. Janicki. The Role of Benralizumab in Eosinophilic Immune Dysfunctions: A Case Report-Based Literature ReviewCase Reports in Medicine 2023; 2023: 1 doi: 10.1155/2023/8832242
4
Quan M. Nhu, Seema S. Aceves. Current state of biologics in treating eosinophilic esophagitisAnnals of Allergy, Asthma & Immunology 2023; 130(1): 15 doi: 10.1016/j.anai.2022.10.004